|
Problems to read this
email ?
Consult
the on line version
|
 |
|
TWYDIL® Newsletter - April 2008 |
|
|
To forward this newsletter to a friend. |
Dear client, Dear surfer,
We are happy to send you our second newsletter.
We draw your attention to the new rules on prohibited substances for
racing and the new withdrawal periods that TWYDIL® has
established for two products of our range.
Also, you will see that we have been extremely active for the last
months with new scientific studies and some further improved formulations.
Finally, you will see that, since beginning of 2008, TWYDIL®
distribution network in the world expanded with some new countries.
We hope that you find it useful reading.
Philippe HENRY TWYDIL®
Marketing Director |
|
| IMPORTANT INFORMATION : ELEUTHEROSIDES AND HARPAGOSIDES. |
On April 5th, the French National
Racing Federation once again declared in a communiqué
that Eleutherococcus senticosus and Harpagophytum
procumbens fall into the category of substances
prohibited by the racing code.
TWYDIL® reminds its clients that, for
TWYDIL® HIPPACAN+C and
TWYDIL® ARTRIDIL, the official withdrawal period of
48 hours must be respected.
This withdrawal period was determined after scientific
tests conducted two years ago with LCH (Central
laboratory of the International equestrian federation
and official French laboratory of anti-doping control
for animals) and consequently is an official insurance
that
TWYDIL®
HIPPACAN+C and
TWYDIL® ARTRIDIL can be
given in full safety at the recommended quantities until 48 hours before any competition. |
 |
| TWYDIL® recommends sharpest vigilance
about the use of products which –though they contain one
of the substances mentioned above- either do not
indicate any waiting time in their labelling or have not
undergone any residue studies. |
|
|
 |
TWYDIL® ARTRIDIL, AT LAST A THOROUGHLY TESTED JOINT PRODUCT.
After complete reformulation,
TWYDIL® ARTRIDIL has
recently been tested in a double blind scientific trial conducted by Professor Kirschvink.
The study, recently presented at the Geneva veterinary
congress, showed that, in comparison with a placebo group,
TWYDIL® ARTRIDIL decreases the metalloproteinase
(MMP9) activity – which is the main cause of cartilage destruction - and stabilizes chondrocytes.
TWYDIL® ARTRIDIL helps to support healthy joints and to
maintain joint mobility.
TWYDIL® ARTRIDIL is particularly recommended for any
horses under hard training and competition.
Other very good news, thanks to a new manufacturing
process the cost of this world reference
chondroprotector has been considerably reduced. |
|
|
 |
UP-DATED TWYDIL® PAMPHLET.
The TWYDIL® catalogue with information on each product has been updated and is now available.
You may request it from your local TWYDIL® distributor or directly from
TWYDIL® head office at
info@twydil.com
It can also been downloaded it in pdf.
Click here. |
|
|
TWYDIL® HEMATINIC, PROVEN EFFECT ON HAEMATOLOGICAL PARAMETERS.
TWYDIL® HEMATINIC syringes now have larger nozzles in
order to squeeze the paste more easily even when the
ambient temperature is cold.
TWYDIL® HEMATINIC is also
available in liquid form in bottles.
TWYDIL®
HEMATINIC
remains also available in 1 litre
bottles with a less viscous liquid than previously.
TWYDIL® HEMATINIC supplied orally for only 10 days
results in optimum erythrocyte function.
TWYDIL®
HEMATINIC
is particularly useful for horses in
poor condition or needing a tonic effect and, of course,
for those with pale mucosa. |
 |
|
|
 |
TWYDIL® RACING, THE 26 INDISPENSABLE INGREDIENTS.
TWYDIL® RACING now contains magnesium glycinate, a
chelate containing glycine, an additional amino acid.
Composition and concentration of
TWYDIL® RACING (with 14
vitamins, 7 trace elements, 4 amino acids and magnesium)
are recognized as a scientific world reference of ideal
supplementation for competition horses (The Veterinary
Journal’, The oxidant/antioxidant equilibrium in
horses’, Professeur Nathalie Kirschvink, Dr de Moffarts,
Professeur Pierre Lekeux). |
|
|
TWYDIL® SUPPORTS RESEARCH.
During the last few months, several scientific studies
sponsored by TWYDIL® have been presented by different
universities at some of the major veterinary congresses
such as the congress of the ‘World Equine Veterinary
Association in Moscow, at the 10th Congress of equine
medicine and surgery in Geneva, at the Hippos congress
in Belgium, and last but not least, at the recent
congress of the British Equine Veterinary Association.
|
 |
| Photo : The TWYDIL® booth at the
Congress of equine medicine and surgery in Geneva. |
|
|
TWYDIL® 4LEGS AND
TWYDIL® GROWING THINK BIGGER !
In response to the current demand,
TWYDIL®
4LEGS is now
available in 7.5 kg buckets and, of course, continues to
be available in 2 kg buckets.
Also,
TWYDIL®
GROWING previously available only in 3 kg
will also be available in 10 kg buckets in the future.
|
 |
|
|
 |
MORE THAN 70 COUNTRIES IN THE WORLD.
During recent months, several countries such as,
Mauritius, South Korea, Bahrain, Iran, and Malta have
been added to the list of countries where TWYDIL® products are locally distributed.
If you wish to become a TWYDIL® distributor in any of
the countries where the products are not yet locally
available, contact
info@twydil.com or +41612722372. |
|
|
|
|
If you wish to unsubscribe, click here.
Copyright © 2007 PAVESCO AG, Elisabethenstrasse 54, CH-4010 BASEL
Website info
et
General conditions |